Senseonics Holdings, Inc.'s (SENS) CEO Tim Goodnow on Q4 2020 Results - Earnings Call Transcript

Senseonics Holdings, Inc. (NYSE:SENS) Q4 2020 Results Earnings Conference Call March 4, 2021 4:30 PM ET

Company Participants

Lynn Lewis - The Gilmartin Group, IR
Tim Goodnow - President and CEO
Nick Tressler - Chief Financial Officer

Conference Call Participants

Melanie Nuñez - Stifel
Danielle Antalffy - SVB Leerink
Jayson Bedford - Raymond James

Operator

Good afternoon. And welcome to the Senseonics Fourth Quarter 2020 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions]

Please note, this event is being recorded. I would now like to turn the conference over to Lynn Lewis of Investor Relations. Please go ahead.

Lynn Lewis

Thank you very much. And welcome to the Senseonics’ fourth quarter 2020 earnings call. This is Lynn Lewis from The Gilmartin Group.

Before we begin today, let me remind you that the company’s remarks include forward-looking statements. These statements reflect management’s expectations about future events, operating plans, regulatory matters, product enhancements, company performance and other matters and speak only as of the date hereof.

These forward-looking statements involve a number of risks and uncertainties. A list of these factors that could cause actual results to be materially different from those expressed or implied by any of these forward-looking statements is detailed under Risk Factors and elsewhere in our annual report on Form 10-K for the year ended December 31, 2019, our 10-Q for the quarter ended September 30, 2020, and other reports filed with the SEC. These documents are available in the Investor Relations section of our website at www.senseonics.com.

We undertake no obligation to update publicly or revise these forward-looking statements for any reason except as required by law. Also on this call, we will be discussing our 2020 outlook. In light of the COVID-19